Fewer than 1 in 100 'highly allergic' people suffered anaphylaxis following the Pfizer COVID-19 jab

Publicly released:
International
Pfizer-BioNTech_COVID-19_vaccine_(2020)_C By U.S. Secretary of Defense, CC BY 2.0
Pfizer-BioNTech_COVID-19_vaccine_(2020)_C By U.S. Secretary of Defense, CC BY 2.0

An Israeli study of 429 'highly allergic' people who received the Pfizer COVID-19 vaccine found 98 per cent of them (420 people) had no allergic reaction to the jab, 1 per cent (six people) had a mild allergic reaction, and 0.7 per cent (three people) had anaphylactic reactions. The rate of allergic reactions to the Pfizer vaccine is higher among patients with allergies than among those without, the researchers say. They used artificial intelligence to select 'highly allergic' people based on questionnaire responses, and say the same method could be used to select vaccination candidates who are most at risk of an allergic reaction, and who should therefore be supervised while receiving the jab.

Media release

From: JAMA

Allergic Reactions After COVID-19 Vaccination Among Adults With High Allergy Risk

What The Study Did: Researchers describe the assessment and immunization of highly allergic individuals with the Pfizer-BioNTech COVID-19 vaccine, as well as the rate of adverse reactions to the vaccine in this population.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research JAMA, Web page The URL will go live after the embargo ends
Journal/
conference:
JAMA Network Open
Research:Paper
Organisation/s: Tel-Hashomer Hospital, Israel
Funder: This study was supported by the Sheba Fund for Health Services and Research (Registered Association).
Media Contact/s
Contact details are only visible to registered journalists.